Matches in SemOpenAlex for { <https://semopenalex.org/work/W4383743885> ?p ?o ?g. }
- W4383743885 abstract "The PAOLA-1 trial (NCT02477644) reported final survival benefit associated with olaparib plus bevacizumab maintenance treatment of patients with advanced ovarian cancer (AOC) based on molecular status. Our aimed to compare the cost-effectiveness of olaparib plus bevacizumab for overall patients, patients with a breast cancer susceptibility genes (BRCA) mutation, homologous recombination deficiency (HRD), or HRD without BRCA mutations AOC from the context of the American healthcare system.Analysis of health outcomes in life-years (LYs), quality-adjusted life-years (QALYs), and the incremental cost-effectiveness ratio (ICER) in various molecular status-based AOC patient at a $150,000/QALY of willingness-to-pay was performed using a state-transitioned Markov model with a 20-year time horizon. Meanwhile, sensitivity analyses assessments were also used to gauge the model's stability.The ICERs of olaparib plus bevacizumab versus bevacizumab alone were $487,428 ($374,758), $249,579 ($191,649), $258,859 ($198,739), and $270,736 ($206,640) per QALY (LY) in the overall patients, patients with BRCA mutations, patients with HRD, and patients with HRD without BRCA mutations AOC, respectively, which indicated that The ICERs was higher than $150,000/QALY in the US. Progression-free survival (PFS) value and olaparib cost emerged as the primary influencing factors of these findings in the sensitivity analysis.At current cost levels, olaparib plus bevacizumab treatment is not a cost-effective treatment for patients with AOC regardless of their molecular status in the US. However, this maintenance treatment may be more favorable health advantages for patients with BRAC mutations AOC." @default.
- W4383743885 created "2023-07-11" @default.
- W4383743885 creator A5013197248 @default.
- W4383743885 creator A5013857620 @default.
- W4383743885 creator A5024590604 @default.
- W4383743885 creator A5051739465 @default.
- W4383743885 creator A5085248434 @default.
- W4383743885 date "2024-01-01" @default.
- W4383743885 modified "2023-09-24" @default.
- W4383743885 title "Olaparib plus bevacizumab as a first-line maintenance treatment for patients with advanced ovarian cancer by molecular status: an updated PAOLA-1 based cost-effectiveness analysis" @default.
- W4383743885 cites W2036603224 @default.
- W4383743885 cites W2113122060 @default.
- W4383743885 cites W2135947389 @default.
- W4383743885 cites W2332185934 @default.
- W4383743885 cites W2416653885 @default.
- W4383743885 cites W2590203295 @default.
- W4383743885 cites W2901022488 @default.
- W4383743885 cites W2925017121 @default.
- W4383743885 cites W2951714360 @default.
- W4383743885 cites W2969788639 @default.
- W4383743885 cites W2970135300 @default.
- W4383743885 cites W2994977341 @default.
- W4383743885 cites W3002796847 @default.
- W4383743885 cites W3013347515 @default.
- W4383743885 cites W3033718997 @default.
- W4383743885 cites W3040575005 @default.
- W4383743885 cites W3087329275 @default.
- W4383743885 cites W3095003868 @default.
- W4383743885 cites W3157558500 @default.
- W4383743885 cites W3162848795 @default.
- W4383743885 cites W3184295143 @default.
- W4383743885 cites W4200232423 @default.
- W4383743885 cites W4205969063 @default.
- W4383743885 cites W4206841660 @default.
- W4383743885 cites W4226093612 @default.
- W4383743885 cites W4226283539 @default.
- W4383743885 cites W4255412302 @default.
- W4383743885 cites W4283743198 @default.
- W4383743885 cites W4285495392 @default.
- W4383743885 cites W4293440268 @default.
- W4383743885 cites W4294577350 @default.
- W4383743885 cites W4297821473 @default.
- W4383743885 doi "https://doi.org/10.3802/jgo.2024.35.e2" @default.
- W4383743885 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37477106" @default.
- W4383743885 hasPublicationYear "2024" @default.
- W4383743885 type Work @default.
- W4383743885 citedByCount "0" @default.
- W4383743885 crossrefType "journal-article" @default.
- W4383743885 hasAuthorship W4383743885A5013197248 @default.
- W4383743885 hasAuthorship W4383743885A5013857620 @default.
- W4383743885 hasAuthorship W4383743885A5024590604 @default.
- W4383743885 hasAuthorship W4383743885A5051739465 @default.
- W4383743885 hasAuthorship W4383743885A5085248434 @default.
- W4383743885 hasConcept C104317684 @default.
- W4383743885 hasConcept C121608353 @default.
- W4383743885 hasConcept C126322002 @default.
- W4383743885 hasConcept C143998085 @default.
- W4383743885 hasConcept C151730666 @default.
- W4383743885 hasConcept C182979987 @default.
- W4383743885 hasConcept C2776694085 @default.
- W4383743885 hasConcept C2777802072 @default.
- W4383743885 hasConcept C2779343474 @default.
- W4383743885 hasConcept C2779962180 @default.
- W4383743885 hasConcept C2780194787 @default.
- W4383743885 hasConcept C2780427987 @default.
- W4383743885 hasConcept C29456083 @default.
- W4383743885 hasConcept C54355233 @default.
- W4383743885 hasConcept C71924100 @default.
- W4383743885 hasConcept C82381507 @default.
- W4383743885 hasConcept C86803240 @default.
- W4383743885 hasConceptScore W4383743885C104317684 @default.
- W4383743885 hasConceptScore W4383743885C121608353 @default.
- W4383743885 hasConceptScore W4383743885C126322002 @default.
- W4383743885 hasConceptScore W4383743885C143998085 @default.
- W4383743885 hasConceptScore W4383743885C151730666 @default.
- W4383743885 hasConceptScore W4383743885C182979987 @default.
- W4383743885 hasConceptScore W4383743885C2776694085 @default.
- W4383743885 hasConceptScore W4383743885C2777802072 @default.
- W4383743885 hasConceptScore W4383743885C2779343474 @default.
- W4383743885 hasConceptScore W4383743885C2779962180 @default.
- W4383743885 hasConceptScore W4383743885C2780194787 @default.
- W4383743885 hasConceptScore W4383743885C2780427987 @default.
- W4383743885 hasConceptScore W4383743885C29456083 @default.
- W4383743885 hasConceptScore W4383743885C54355233 @default.
- W4383743885 hasConceptScore W4383743885C71924100 @default.
- W4383743885 hasConceptScore W4383743885C82381507 @default.
- W4383743885 hasConceptScore W4383743885C86803240 @default.
- W4383743885 hasLocation W43837438851 @default.
- W4383743885 hasLocation W43837438852 @default.
- W4383743885 hasOpenAccess W4383743885 @default.
- W4383743885 hasPrimaryLocation W43837438851 @default.
- W4383743885 hasRelatedWork W2950446512 @default.
- W4383743885 hasRelatedWork W2994977341 @default.
- W4383743885 hasRelatedWork W3015072749 @default.
- W4383743885 hasRelatedWork W3047344552 @default.
- W4383743885 hasRelatedWork W3090114554 @default.
- W4383743885 hasRelatedWork W3126466062 @default.
- W4383743885 hasRelatedWork W3154406130 @default.
- W4383743885 hasRelatedWork W3204368990 @default.
- W4383743885 hasRelatedWork W4283025800 @default.